Personalized Medicine

Papers
(The TQCC of Personalized Medicine is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
Application of Transcriptomics and Proteomics in Pulmonary Arterial Hypertension17
Developing the Workplace Learning Social System: considerations for genomics implementation and workforce preparedness17
A scoping review of the cost-effectiveness of precision treatment in chronic lymphocytic leukemia15
Perceived understanding and psychosocial outcomes: employees’ responses to learning results of workplace genetic testing15
Pharmacogenomics education in China and the United States: advancing personalized medicine13
miR-559 rs58450758 polymorphism is associated with colorectal cancer risk and prognosis in Chinese Han population11
An evidence gap map of the personalized medicine in bladder cancer11
Predictive value of miR-132-3p for the onset of sepsis-induced acute kidney injury and its functional role during disease development10
Refining Personalized Diagnosis, Treatment and Exploitation of Hypothyroidism Related to Solid Nonthyroid Cancer8
Mutational signatures in appendiceal adenocarcinomas: potential for future personalization in hyperthermic intraperitoneal chemotherapy?8
The rs2275738 variant of the adiponectin receptor 1 gene is associated with biopsy-proven nonalcoholic fatty liver disease8
Genetic Predisposition for the Development of Lamotrigine-Induced Stevens–Johnson Syndrome/Toxic Epidermal Necrolysis: a Systematic Review and Meta-Analysis8
Precision acute medical care through “-omic” analyses: a scoping review8
Association between IL-6, miRNA-146a, MALAT1 genetic polymorphisms and risk of rheumatoid arthritis8
Val66Met polymorphism in the BDNF gene and antidepressant response in depression: an updated meta-analysis7
Knowledge, attitudes and practice regarding pharmacovigilance and adverse drug reaction reporting among physicians and pharmacists in Egypt: a step toward personalized medicine implementation6
Polygenic risk scores to refine Breast cancer screening and prevention strategies6
Enhancing Parkinson’s disease prediction using meta-heuristic optimized machine learning models6
Precision medicine activities and opportunities for shaping maternal and neonatal health in Qatar6
The effect of RNLS gene polymorphisms on preeclampsia susceptibility: a meta-analysis study6
MYC variant at 8q24 increases susceptibility to urinary bladder cancer: a meta-analysis of 53,957 individuals6
Leveraging circulating microRNAs for personalized disease-modifying therapies in type 1 diabetes5
Identification of novel variants of XPA and POLH/XPV genes in xeroderma pigmentosum patients in Vietnam5
Association of a common SOD gene variant with ARHL risk: analysis by age, hearing threshold, and enzyme activity5
Gene expression profiling of peripheral blood in patients with steroid-induced osteonecrosis of the femoral head5
Looking Back Over 2023 and Welcome to the 21 st Issue of Personalized Medicine5
Digital biomarkers in chronic disease management: a systematic review of personalization and ethical challenges5
Cost–effectiveness and budget impact analysis of screening strategies for maturity-onset diabetes of the young in three European countries5
Deciphering the multi-organ anti-fibrotic mechanisms of pirfenidone and nintedanib via network pharmacology5
Identification of Dpyd Variants and Estimation of Uracil and Dihydrouracil in A Healthy Indian Population4
Development of Competency-based Online Genomic Medicine Training (COGENT)4
Genomics and the early diagnosis of lung cancer4
HEcoPerMed, Personalized Medicine from a Health Economic Perspective: Lessons Learned and Potential Opportunities Ahead4
Regional disparities in access to gene therapies in the European Union, the United States, Japan, and China4
Diagnostic Utility of the 23-gene Expression Profile Test for an Atypical Intradermal Melanocytic Proliferation4
Cost–effectiveness of extended DPYD testing before fluoropyrimidine chemotherapy in metastatic breast cancer in the UK4
Association of miR-21 gene polymorphisms with cognitive function in patients with systemic lupus erythematosus4
Machine learning–enabled early risk stratification of β-Iactam–induced electrolyte imbalances4
Whole-exome sequencing reveals novel variants associated with abnormal uterine bleeding caused by copper intrauterine device4
Cloud-based Digital Healthcare Development for Precision Medical Hospital Information System4
Association between CYP11B2 rs1799998 genetic variant with essential hypertension and antihypertensive response4
Global harmonization in advanced therapeutics: balancing innovation, safety, and access3
Pharmacogenomics of Lipid-Lowering Agents: the Impact on Efficacy and Safety3
Genetic and non-genetic factors influencing the therapeutic response of valproic acid in pediatric epileptic patients3
Recent Advances in Personalized Cancer Immunotherapy with Immune Checkpoint Inhibitors, T Cells and Vaccines3
The genetic association of IL-17A rs8193036 with the susceptibility to Alzheimer’s disease3
Lung cancer, platinum analog-based frontline treatment and pharmacogenetic limitations3
Development of a computer-based tool to obtain a family health history in Vietnam3
A rare likely pathogenic HLA-DRB1 variant with compromised immunity in severe COVID-19 patient and in-hospital mortality3
A Real-World Analysis of Tyrosine Receptor Kinase Inhibitor-Related Toxicities in Cancer Treatment3
Tailoring pediatric vancomycin doses: achieving therapeutic levels and minimizing toxicity in oncology patients3
Evaluation of pharmacogenomic information in drug labeling: a case study from Jordan3
Patient-Derived Tumour Organoids (PDOs) may help oncologists in clinical practice3
The correlation between the polymorphism of lysolecithin acyltransferase (MBOAT7) rs641738 and liver fibrosis3
The norepinephrine dosing dilemma in septic shock: a narrative review3
Low Rate of Complications in Nipple-Sparing Mastectomy for Patients with BRCA1 and BRCA2 Mutation3
Association of miR-21 rs1292037 polymorphism with congenital heart disease susceptibility in Chinese children3
From genomes to metabolomes: adaptive science in personalized medicine3
0.11442184448242